Literature DB >> 19646308

Staphylococcus aureus is the most common identified cause of cellulitis: a systematic review.

S Chira1, L G Miller.   

Abstract

We utilized Medline to perform a systematic review of the literature to quantify the aetiology of cellulitis with intact skin. Of 808 patients with cellulitis, 127-129 (15.7-16.0%) patients had positive needle aspiration and/or punch biopsy cultures from intact skin. Of the patients with positive cultures, 65 (50.4-51.2%) had cultures positive for Staphylococcus aureus, 35 (27.1-27.6%) for group A streptococcus, and 35-37 (27.1-29.1%) for other pathogens. The most common aetiology of cellulitis with intact skin, when it can be determined, is S. aureus, outnumbering group A streptococcus by a ratio of nearly 2:1. Given the increasing incidence of community-associated methicillin-resistant S. aureus infections, our findings may have critical therapeutic implications.

Entities:  

Mesh:

Year:  2009        PMID: 19646308     DOI: 10.1017/S0950268809990483

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  27 in total

1.  A microscale, full-thickness, human skin on a chip assay simulating neutrophil responses to skin infection and antibiotic treatments.

Authors:  Jae Jung Kim; Felix Ellett; Carina N Thomas; Fatemeh Jalali; R Rox Anderson; Daniel Irimia; Adam B Raff
Journal:  Lab Chip       Date:  2019-09-10       Impact factor: 6.799

Review 2.  Management of acute bacterial skin and skin structure infections with a focus on patients at high risk of treatment failure.

Authors:  Abraham Pulido-Cejudo; Mario Guzmán-Gutierrez; Abel Jalife-Montaño; Alejandro Ortiz-Covarrubias; Jose Luis Martínez-Ordaz; Héctor Faustino Noyola-Villalobos; Luis Mauricio Hurtado-López
Journal:  Ther Adv Infect Dis       Date:  2017-08-31

3.  Evidence of streptococcal origin of acute non-necrotising cellulitis: a serological study.

Authors:  M Karppelin; T Siljander; A-M Haapala; J Aittoniemi; R Huttunen; J Kere; J Vuopio; J Syrjänen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-11-18       Impact factor: 3.267

4.  PCR offers no advantage over culture for microbiologic diagnosis in cellulitis.

Authors:  K E Johnson; D E Kiyatkin; A T An; S Riedel; J Melendez; J M Zenilman
Journal:  Infection       Date:  2012-07-17       Impact factor: 3.553

5.  Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections.

Authors:  Loren G Miller; Robert S Daum; C Buddy Creech; David Young; Michele D Downing; Samantha J Eells; Stephanie Pettibone; Rebecca J Hoagland; Henry F Chambers
Journal:  N Engl J Med       Date:  2015-03-19       Impact factor: 91.245

6.  Antimicrobial Activities of Ceftaroline and Comparator Agents against Bacterial Organisms Causing Bacteremia in Patients with Skin and Skin Structure Infections in U.S. Medical Centers, 2008 to 2014.

Authors:  Helio S Sader; Robert K Flamm; Rodrigo E Mendes; David J Farrell; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

7.  Blood culture associations in children with a diagnosis of cellulitis in the era of methicillin-resistant Staphylococcus aureus.

Authors:  David Wathen; Donna R Halloran
Journal:  Hosp Pediatr       Date:  2013-04

8.  Late-onset extensive haematoma mimicking cellulitis.

Authors:  Yoo S Baek; Jin Y Song; Kyung M Jeong; Jiehyun Jeon
Journal:  Int Wound J       Date:  2018-10-31       Impact factor: 3.315

9.  Is coverage of S. aureus necessary in cellulitis/erysipelas? A literature review.

Authors:  Stamatis Karakonstantis
Journal:  Infection       Date:  2019-12-16       Impact factor: 3.553

10.  Effect of Cephalexin Plus Trimethoprim-Sulfamethoxazole vs Cephalexin Alone on Clinical Cure of Uncomplicated Cellulitis: A Randomized Clinical Trial.

Authors:  Gregory J Moran; Anusha Krishnadasan; William R Mower; Fredrick M Abrahamian; Frank LoVecchio; Mark T Steele; Richard E Rothman; David J Karras; Rebecca Hoagland; Stephanie Pettibone; David A Talan
Journal:  JAMA       Date:  2017-05-23       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.